Europe's medicines ‌regulator ‌on Friday recommended ​granting marketing authorisation to mCombriax, ‌making ⁠Moderna's messenger RNA vaccine ⁠the world's ​first ​combined ​shot for ...

The company has had its ups -- the approval of its respiratory syncytial virus (RSV) vaccine back in 2024 -- and its downs -- the failure of its cytomegalovirus (CMV) vaccine candidate in a phase 3 ...

This prompts a reassessment of the stock’s value to determine if this represents a genuine opportunity or a potential trap.

The onset of the COVID-19 pandemic was a global event and a material shock to the world's healthcare system. Moderna used its mRNA technology to help develop a vaccine in record time. The company's ...

The Food and Drug Administration agreed Wednesday to review Moderna’s application to make a new seasonal flu shot available, after initially refusing to do so. The back-and-forth reveals increased ...

The stock’s movement comes after the U.S. Food and Drug Administration (FDA) notified Moderna that its biologics license ...

Moderna expects international markets to drive 2026 growth CEO Bancel warns U.S. regulatory uncertainty may hinder domestic access to new therapies Shares rise over 10% after reporting results Feb 13 ...

Since being sworn in as Health and Human Services (HHS) secretary, Robert F. Kennedy Jr has repeatedly tried to undermine public trust in vaccines. His agency recently took steps to slow down the ...

The Food and Drug Administration’s recent decision to turn away Moderna’s application for a new flu shot for older Americans is a troubling development in health officials’ piecemeal dismantling of ...

The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying the company’s clinical trial design put patients at risk. The FDA’s defense ...

The Food and Drug Administration refused to review Moderna’s application for its new mRNA flu vaccine — a move the pharma giant’s’s president Dr. Stephen Hoge said left him in “complete shock.” In an ...

Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...